The Food and Drug Administration issued the world's first approval of a vaccine against respiratory syncytial virus (RSV), an achievement that researchers have worked toward for decades after a catastrophic clinical trial in the 1960s.The vaccine, called Arexvy from pharmaceutical giant GSK, is approved for adults aged 60 and over.
#researchers #participants #disease-control #hospitalizations #immune-system #older-adults #hospitalization #immune-systems #immunizations
[
add
]
[
|
|
...
]